Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soohyeon Lee

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Stem Cells (Dayton, Ohio)|July 14, 2018
Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple PopulationsSuji Lee, Ji Young Huh, David M Turner, et al.
BMC Cancer|May 9, 2024
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, et al.
Cancer Research and Treatment|April 2, 2016
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort StudySe Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.
Cytokine|March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Breast Cancer Research and Treatment|June 3, 2015
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.
Nature Communications|May 2, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signaturesZhengyan Kan, Ying Ding, Jinho Kim, et al.
Journal of Cancer Research and Clinical Oncology|March 28, 2022
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimenSeung-Hoon Beom, Jong Gwang Kim, Seung Hyuk Baik, et al.
Cancer Medicine|November 14, 2022
Perception and safety analysis of COVID-19 vaccination in cancer patients: A multicenter, real-world studyKyoungmin Lee, In Hae Park, Sang Cheul Oh, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Stem Cells (Dayton, Ohio)|July 14, 2018
Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple PopulationsSuji Lee, Ji Young Huh, David M Turner, et al.
BMC Cancer|May 9, 2024
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, et al.
Cancer Research and Treatment|April 2, 2016
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort StudySe Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.
Cytokine|March 26, 2021
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)Ju Won Kim, Soohyeon Lee, Hye Sook Kim, et al.
Breast Cancer Research and Treatment|June 3, 2015
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02)Yeon Hee Park, Kyung Hae Jung, Seock-Ah Im, et al.
Nature Communications|May 2, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signaturesZhengyan Kan, Ying Ding, Jinho Kim, et al.
Journal of Cancer Research and Clinical Oncology|March 28, 2022
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimenSeung-Hoon Beom, Jong Gwang Kim, Seung Hyuk Baik, et al.
Cancer Medicine|November 14, 2022
Perception and safety analysis of COVID-19 vaccination in cancer patients: A multicenter, real-world studyKyoungmin Lee, In Hae Park, Sang Cheul Oh, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
Pageof 10